Capital & FinanceEvent: September 1, 2026
Accelerating Clinical Trials Ltd will soon open ATICUS, a paediatric network, with support from Cure Leukaemia.
Published
Signal category
Capital & Finance
Quote
“We will soon open ATICUS, a paediatric network, with support form Cure Leukaemia.”
— Accelerating Clinical Trials Ltd team
Company
Accelerating Clinical Trials Ltd
ACT specialises in delivering UK blood cancer studies in collaboration with two established networks TAP and IMPACT
- Industry
- Research Services
- Location
- Birmingham, GB
- Company size
- 26 employees
A not-for-profit company, any surplus income is reinvested for blood cancer patients’ benefit. Delivery of both academic investigator initiated and industry sponsored clinical trials in haemato-oncology are accelerated with the resource and expertise of ACT and the networks, TAP and IMPACT.
Founded 2021